Male Reproductive Cancers Resource Center
According to a study across all 32 cancer types, data suggest that 66% of mutations leading to cancer are the result of random events.
According to the AACI, proposed budget cuts by the White House would likely mean a cut of close to $1 billion for the National Cancer Institute.
Male Reproductive Cancers News
Researchers developed a novel Bayesian adaptive randomization method that maximizes efficiency by focusing the algorithm to reduce uncertainty within patient-treatment baskets.
More Male Reproductive Cancers Resources
This fact sheet answers some common questions about prostate cancer, bone scan, and metastasis.
This fact sheet reviews current prostate cancer screening tests, guidelines, PSA, and risk factors.
This fact sheet provides information on symptoms, pain, causes, and treatments for testicular, testicle cancer.
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- In Focus: Atezolizumab for Non-small Cell Lung Cancer
- FDA Warns 14 Companies To Stop Selling Illegal Cancer Treatments
- ASCO Releases Opinion on Hormonal Therapy for Castrate-resistant Prostate Cancer
- Pembrolizumab for Advanced Melanoma: Efficacy and Toxicity
- Bladder Cancer: Immunotherapies, Combination Therapies, and Current Research